{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:13:46Z","timestamp":1786990426227,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["20220817214511001"],"award-info":[{"award-number":["20220817214511001"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515012156"],"award-info":[{"award-number":["2022A1515012156"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijbiomac.2025.144949","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:59:59Z","timestamp":1748951999000},"page":"144949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Inflammation-retentive hyaluronic acid-mesalamine conjugate for enhanced oral therapy in ulcerative colitis"],"prefix":"10.1016","volume":"318","author":[{"given":"Yulin","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengning","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"73","key":"10.1016\/j.ijbiomac.2025.144949_bb0005","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10114","key":"10.1016\/j.ijbiomac.2025.144949_bb0010","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144949_bb0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ibd.21048","article-title":"World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010","volume":"16","author":"Bernstein","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144949_bb0020","first-page":"616","article-title":"Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study, lancet","volume":"6","author":"Prof Nicholas","year":"2021","journal-title":"Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144949_bb0025","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/ecco-jcc\/jjaa050","article-title":"Combined biologic and immunomodulatory therapy is superior to monotherapy for decreasing the risk of inflammatory bowel disease-related complications","volume":"14","author":"Targownik","year":"2020","journal-title":"J. Crohns Colitis"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144949_bb0030","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00384-021-03857-2","article-title":"Surgical management of Crohn's disease: a state of the art review","volume":"36","author":"Meima-van Praag","year":"2021","journal-title":"Int. J. Color. Dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144949_bb0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1517\/17425247.5.5.483","article-title":"Target-specific drug release to the colon","volume":"5","author":"Jain","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144949_bb0040","article-title":"Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease","volume":"19","author":"Zheng","year":"2024","journal-title":"Asian J Pharm Sci"},{"issue":"524","key":"10.1016\/j.ijbiomac.2025.144949_bb0045","first-page":"1","article-title":"Advances in oral drug delivery for regional targeting in the gastrointestinal tract - influence of physiological, pathophysiological and pharmaceutical factors","volume":"11","author":"Hua","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/JIR.S65979","article-title":"Inflammatory bowel disease: clinical aspects and treatments","volume":"7","author":"Fakhoury","year":"2014","journal-title":"J. Inflamm. Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144949_bb0055","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/cpt.1609","article-title":"Achieving mucosal healing in inflammatory bowel diseases: which drug concentrations need to be targeted?","volume":"106","author":"Van den Berghe","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144949_bb0060","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/jgh.15059","article-title":"Mucosal concentrations of N-acetyl-5-aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine","volume":"35","author":"Fukuda","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144949_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00054725-200108000-00007","article-title":"Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine","volume":"7","author":"Naganuma","year":"2001","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0070","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/gut.47.3.410","article-title":"Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis","volume":"47","author":"Frieri","year":"2000","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144949_bb0075","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ibd.20099","article-title":"5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review","volume":"13","author":"Gisbert","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"issue":"300","key":"10.1016\/j.ijbiomac.2025.144949_bb0080","doi-asserted-by":"crossref","first-page":"300ra128","DOI":"10.1126\/scitranslmed.aaa5657","article-title":"An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144949_bb0085","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.apsb.2020.11.003","article-title":"Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: opportunities and emerging strategies","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144949_bb0090","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.apsb.2020.11.003","article-title":"Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: opportunities and emerging strategies","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144949_bb0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2017.08.118","article-title":"Modeling of the burst release from PLGA micro- and nanoparticles as function of physicochemical parameters and formulation characteristics","volume":"532","author":"de Azevedo","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144949_bb0100","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144949_bb0105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.addr.2013.01.002","article-title":"Targeted nanoparticles with novel non-peptidic ligands for oral delivery","volume":"65","author":"des Rieux","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144949_bb0110","article-title":"Modulation of gut barrier functions in ulcerative colitis by hyaluronic acid system","volume":"9","author":"Kotla","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/JIR.S393495","article-title":"Anti-inflammatory effects of the 35kDa hyaluronic acid fragment (B-HA\/HA35)","volume":"16","author":"Jia","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140146","article-title":"Hyaluronic acid-conjugated lipid nanocarriers in advancing cancer therapy: a review","volume":"299","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2025.144949_bb0125","article-title":"Development of a dexamethasone-hyaluronic acid conjugate with selective targeting effect for acute lung injury therapy","volume":"280","author":"Chen","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"201","key":"10.1016\/j.ijbiomac.2025.144949_bb0130","first-page":"1","article-title":"Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer","volume":"6","author":"Misra","year":"2015","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144949_bb0135","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/molecules22060904","article-title":"Combined treatment with hyaluronic acid and mesalamine protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzenesulfonic acid","volume":"22","author":"Chiu","year":"2017","journal-title":"Molecules"},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.144949_bb0140","doi-asserted-by":"crossref","first-page":"28827","DOI":"10.1021\/acsomega.4c03240","article-title":"pH-sensitive hydrogels fabricated with hyaluronic acid as a polymer for site-specific delivery of mesalamine","volume":"9","author":"Liaqat","year":"2024","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144949_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscia.2023.100014","article-title":"Nanoparticle-enhanced mesalazine therapy for inflammatory bowel disease","volume":"1","author":"Sutaria","year":"2023","journal-title":"Pharmaceutical Science Advances"},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116300","article-title":"Solubility study of mesalazine in the aqueous mixtures of a deep-eutectic solvent at different temperatures","volume":"336","author":"Zarghampour","year":"2021","journal-title":"J. Mol. Liq."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144949_bb0155","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1053\/j.gastro.2009.08.055","article-title":"Regulation of colonic epithelial repair in mice by toll-like receptors and hyaluronic acid","volume":"137","author":"Zheng","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00101","article-title":"Hyaluronan, a crucial regulator of inflammation","volume":"5","author":"Petrey","year":"2014","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144949_bb0165","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/bm050867v","article-title":"Degradative action of reactive oxygen species on hyaluronan","volume":"7","author":"Soltes","year":"2006","journal-title":"Biomacromolecules"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144949_bb0170","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/MIB.0b013e318297d741","article-title":"Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells","volume":"19","author":"Managlia","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144949_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.polymer.2006.11.010","article-title":"A new simple procedure to calculate monomer reactivity ratios by using on-line H NMR kinetic experiments: copolymerization system with greater difference between the monomer reactivity ratios","volume":"48","author":"Abdollahi","year":"2007","journal-title":"Polymer"},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.polymertesting.2016.10.013","article-title":"Determination of molar ratio of primary secondary and tertiary amines in polymers by applying derivatization and NMR spectroscopy","volume":"56","author":"Liu","year":"2016","journal-title":"Polym. Test."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144949_bb0185","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1038\/s41598-022-10400-y","article-title":"Dual role of melatonin as an anti-colitis and anti-extra intestinal alterations against acetic acid-induced colitis model in rats","volume":"12","author":"Ahmed","year":"2022","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.144949_bb0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.chroma.2006.01.058","article-title":"High-performance liquid-chromatographic determination of 5-aminosalicylic acid and its metabolites in blood plasma","volume":"1119","author":"Nobilis","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0195","first-page":"3678","article-title":"Investigating intestinal inflammation in DSS-induced model of IBD","volume":"60","author":"Kim","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144949_bb0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0023677219883319","article-title":"Defining body-weight reduction as a humane endpoint: a critical appraisal","volume":"54","author":"Talbot","year":"2020","journal-title":"Lab. Anim."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0205","series-title":"Animal models of allergic disease: methods and protocols","first-page":"267","article-title":"Preservation and processing of intestinal tissue for the assessment of histopathology","author":"Rieger","year":"2021"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144949_bb0210","first-page":"4557","article-title":"A guide to histomorphological evaluation of intestinal inflammation in mouse models","volume":"7","author":"Erben","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.144949_bb0215","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1002\/anie.201602525","article-title":"Bilirubin nanoparticles as a nanomedicine for anti-inflammation therapy","volume":"55","author":"Lee","year":"2016","journal-title":"Angew. Chem. Int. Edit."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144949_bb0220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41563-019-0462-9","article-title":"Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis","volume":"19","author":"Lee","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2020.582218","article-title":"Immunofluorescence staining of paraffin sections step by step","volume":"14","author":"Zaqout","year":"2020","journal-title":"Front. Neuroanat."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144949_bb0230","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3390\/polym15040966","article-title":"Granular disulfide-crosslinked hyaluronic hydrogels: a systematic study of reaction conditions on thiol substitution and injectability parameters","volume":"15","author":"Perez","year":"2023","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejps.2017.09.037","article-title":"New mesalamine polymeric conjugate for controlled release: preparation, characterization and biodistribution study","volume":"111","author":"Cesar","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpba.2018.09.020","article-title":"Diffusion ordered NMR spectroscopy measurements as screening method of potential reactions of API and excipients in drug formulations","volume":"162","author":"Becht","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144949_bb0245","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1021\/acs.bioconjchem.5b00242","article-title":"Polysaccharide-based conjugates for biomedical applications","volume":"26","author":"Basu","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118662","article-title":"Chemical synthesis of polysaccharide-protein and polysaccharide-peptide conjugates: a review","volume":"274","author":"Zhou","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.144949_bb0255","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.3390\/molecules28248105","article-title":"Oxidation of Mesalamine under phenoloxidase- or peroxidase-like enzyme catalysis","volume":"28","author":"El Zein","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0260","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4292\/wjgpt.v7.i2.242","article-title":"Oral tolerance is inducible during active dextran sulfate sodium-induced colitis","volume":"7","author":"Ino","year":"2016","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0265","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.abb.2018.03.012","article-title":"Myeloperoxidase in the inflamed colon: a novel target for treating inflammatory bowel disease","volume":"645","author":"Chami","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144949_bb0270","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41575-018-0079-5","article-title":"Control and dysregulation of redox signalling in the gastrointestinal tract","volume":"16","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120153","article-title":"Absorption, metabolism, and functions of hyaluronic acid and its therapeutic prospects in combination with microorganisms: a review","volume":"299","author":"Zheng","year":"2023","journal-title":"Carbohydr. Polym."},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.144949_bb0280","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1021\/jf8017029","article-title":"Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs","volume":"56","author":"Balogh","year":"2008","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144949_bb0285","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10967-015-3986-8","article-title":"Simple and efficient radiolabeling of hyaluronic acid and its in vivo evaluation via oral administration","volume":"305","author":"Ma","year":"2015","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0290","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejpb.2020.07.007","article-title":"Transfer of orally administered hyaluronan to the lymph","volume":"154","author":"Sato","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0295","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1021\/mp9000926","article-title":"Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa","volume":"6","author":"Boaz","year":"2009","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144949_bb0300","first-page":"276","article-title":"Increased fecal eosinophil cationic protein in inflammatory bowel disease","volume":"40","author":"Berstad","year":"1993","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144949_bb0305","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1471-4914(01)01963-3","article-title":"A crucial role for CD44 in inflammation","volume":"7","author":"Pure","year":"2001","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144949_bb0310","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4062\/biomolther.2020.227","article-title":"Hyaluronic acid increases anti-inflammatory eficacy of rectal 5-amino salicylic acid administration in a murine colitis model","volume":"29","author":"Jhundoo","year":"2021","journal-title":"Biomol Ther (Seoul)"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144949_bb0315","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3390\/pharmaceutics14102118","article-title":"Hyaluronic acid-conjugated PLGA nanoparticles alleviate ulcerative colitis via CD44-mediated dual targeting to inflamed colitis tissue and macrophages","volume":"14","author":"Hlaing","year":"2022","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144949_bb0320","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.15710","article-title":"Combination therapy for ulcerative colitis: orally targeted nanoparticles prevent mucosal damage and relieve inflammation","volume":"6","author":"Xiao","year":"2016","journal-title":"Theranostics"},{"issue":"eado8222","key":"10.1016\/j.ijbiomac.2025.144949_bb0325","first-page":"1","article-title":"Artificial mucus layer formed in response to ROS for the oral treatment of inflammatory bowel disease","volume":"10","author":"Zhang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0330","article-title":"CD44-targeted Nanocarrier for Cancer therapy","volume":"12","author":"Kesharwani","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144949_bb0335","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.drudis.2016.12.009","article-title":"Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy","volume":"22","author":"Wickens","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144949_bb0340","doi-asserted-by":"crossref","first-page":"13037","DOI":"10.1021\/acsnano.2c05558","article-title":"Design of diselenide-bridged hyaluronic acid nano-antioxidant for efficient ROS scavenging to relieve colitis","volume":"16","author":"Xu","year":"2022","journal-title":"ACS Nano"},{"issue":"35","key":"10.1016\/j.ijbiomac.2025.144949_bb0345","doi-asserted-by":"crossref","first-page":"46090","DOI":"10.1021\/acsami.4c09901","article-title":"Acid-resistant nano-antioxidants based on epigallocatechin gallate alleviate acute intestinal and kidney inflammation","volume":"16","author":"Pan","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0350","first-page":"71","article-title":"An olsalazine nanoneedle-embedded inulin hydrogel reshapes intestinal homeostasis in inflammatory bowel disease","volume":"33","author":"Zhang","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0355","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jconrel.2024.11.070","article-title":"Establishment of a 3D multi-layered in vitro model of inflammatory bowel disease","volume":"377","author":"Ferreira","year":"2025","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144949_bb0360","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3748\/wjg.v29.i7.1157","article-title":"Mucosal healing and inflammatory bowel disease: therapeutic implications and new targets","volume":"29","author":"Otte","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144949_bb0365","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1097\/MIB.0000000000000117","article-title":"Mucus layers in inflammatory bowel disease","volume":"20","author":"Johansson","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144949_bb0370","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1742-1241.2007.01665.x","article-title":"Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn\u2019s disease","volume":"62","author":"Strugala","year":"2008","journal-title":"Int. J. Clin. Pract."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144949_bb0375","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/gut.2006.098160","article-title":"Comparative study of the intestinal mucus barrier in normal and inflamed colon","volume":"56","author":"Swidsinski","year":"2007","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144949_bb0380","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41575-020-0331-7","article-title":"Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD","volume":"17","author":"Kudelka","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0385","doi-asserted-by":"crossref","first-page":"431231","DOI":"10.1155\/2013\/431231","article-title":"Mucosal barrier in ulcerative colitis and Crohn\u2019s disease","volume":"2013","author":"Dorofeyev","year":"2013","journal-title":"Gastroenterol. Res. Pract."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144949_bb0390","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-022-00604-y","article-title":"Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?","volume":"19","author":"Villablanca","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.144949_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.12.044","article-title":"Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease","volume":"354","author":"Pu","year":"2023","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144949_bb0400","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1039\/D3BM01645E","article-title":"Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review","volume":"12","author":"Liu","year":"2024","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144949_bb0405","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1021\/acsnano.3c05732","article-title":"An engineered butyrate-derived polymer nanoplatform as a mucosa-healing enhancer potentiates the therapeutic effect of magnolol in inflammatory bowel disease","volume":"18","author":"Fan","year":"2024","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144949_bb0410","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2021.08.047","article-title":"The tight junction protein ZO-1 is dispensable for barrier function but critical for effective mucosal repair","volume":"161","author":"Kuo","year":"2021","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144949_bb0415","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144949_bb0420","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/SGA.0000000000000026","article-title":"Mesalamine-induced nephrotoxicity in the treatment of Crohn disease: a case study","volume":"37","author":"Chen","year":"2014","journal-title":"Gastroenterol. Nurs."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144949_bb0425","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1572-0241.1999.01324.x","article-title":"Mesalamine-associated thrombocytopenia","volume":"94","author":"Farrell","year":"1999","journal-title":"Am. J. Gastroenterol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025055023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025055023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T16:22:10Z","timestamp":1752942130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025055023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":85,"alternative-id":["S0141813025055023"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144949","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation-retentive hyaluronic acid-mesalamine conjugate for enhanced oral therapy in ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"144949"}}